Bluesky Facebook Reddit Email

Immunotherapy: Enhancing the therapeutic effectiveness of photothermal cancer treatments

09.15.20 | Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.


The immunosuppression status within most tumors is a great challenge for the efficacy of immune checkpoint blockade, as no efficient or durable antitumor immune response would be set up or maintained. Ablation effect of photothermal therapy could cause immunogenic cell death and subsequently released damaged-associated molecular patterns act as an endogenous danger signal, hence improving the tumor immunogenicity. To improve the success rate of the therapeutic effect of immune checkpoint blockade, it would be desirable to combine with photosensitizers to potentiate antitumor immunity.

Anti-CD47 antibody (aCD47), a CD47/SIRPα axis blockade agent, has demonstrated excellent efficacy against various kinds of tumors. However aCD47 as monotherapy induces modest phagocytic activity and low response rate , resulting in failures in clinical trials. In a new paper published in Light Science & Application , a team of scientists, led by Professor Han Zhang and Professor Paras N. Prasad, reported the use of near-infrared light-induced heat to ablate tumor together with aCD47 for enhanced cancer treatment.

These scientists summarize the mechanism of this combination strategy:

(2) Light-irradiated BP in combination with aCD47, strongly suppresses proliferation and growth of cancer cells, exerting a significant synergistically enhanced antitumor effect.

(3) BP based hyperthermic ablation plus aCD47 treatment may induce abscopal effect and promises for inhibition of metastatic cancers.

"In short, BP based photothermal effect moderates immunosuppression in a tumor microenvironment , which further enhances antitumor immunities to facilitate aCD47 blockade cancer immunotherapy. The innate and adaptive immunity activated by BP photothermal effect plus aCD47 combined therapy leads to promotion of local and systemic anticancer immune responses. This combination strategy provides a promising platform to enhance the therapeutic efficacy of aCD47 in solid tumors. Given the excellent biodegradability property of BP, it is possible that this light-induced synergistic therapy mode has great potential in biomedical applications and clinical translation."

###

10.1038/s41377-020-00388-3

Keywords

Article Information

Contact Information

Paras N. Prasad
pnprasad@buffalo.edu

How to Cite This Article

APA:
Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS. (2020, September 15). Immunotherapy: Enhancing the therapeutic effectiveness of photothermal cancer treatments. Brightsurf News. https://www.brightsurf.com/news/L3RKJZY8/immunotherapy-enhancing-the-therapeutic-effectiveness-of-photothermal-cancer-treatments.html
MLA:
"Immunotherapy: Enhancing the therapeutic effectiveness of photothermal cancer treatments." Brightsurf News, Sep. 15 2020, https://www.brightsurf.com/news/L3RKJZY8/immunotherapy-enhancing-the-therapeutic-effectiveness-of-photothermal-cancer-treatments.html.